Lack of kinin B1 receptor potentiates leptin action in the liver

Journal of Molecular Medicine

Volumn 91, Issue 7, 2013, Pages 851-860

  Fonseca, Raphael Gomes ^a   Sales, Vicencia Micheline ^a   Ropelle, Eduardo ^b   Barros, Carlos Castilho ^a   Oyama, Lila ^a   Ihara, Silvia Saiuli Iuki ^a   Saad, Mário Jose Abdalla ^b   Araújo, Ronaldo Carvalho ^a   Pesquero, João Bosco ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Insulin; Kinins; Leptin; Liver; Non alcoholic fatty liver disease

Indexed keywords

ACYL COENZYME A DESATURASE; FETUIN A; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE 2; KININ; KININ B1 RECEPTOR; LEPTIN; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; RESISTIN; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIPID STORAGE; LIPOGENESIS; LIVER FUNCTION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT;

ADIPOKINES; ANIMALS; DIET, HIGH-FAT; FATTY LIVER; LEPTIN; LIVER; MALE; MICE; MICE, KNOCKOUT; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, LEPTIN; STEAROYL-COA DESATURASE;

EID: 84879844035     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1004-6     Document Type: Article

References (40)

1. Tilg H, Moschen AR (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 19:371-379
2. Alba LM, Lindor K (2003) Review article: non-alcoholic fatty liver disease. Aliment Pharmacol Ther 17:977-986
3. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77
4. Bhoola KD, Figueroa CD, Worthy K (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44:1-80
5. Mori MA, Araujo RC, Pesquero JB (2008) Kinin B1 receptor stimulation modulates leptin homeostasis. Evidence for an insulin-dependent mechanism. Int Immunopharmacol 8:242-246
6. Mori MA, Araujo RC, Reis FC, Sgai DG, Fonseca RG, Barros CC, Merino VF, Passadore M, Barbosa AM, Ferrari B et al (2008) Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 57:1491-1500
7. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546
8. Carvalheira JB, Ribeiro EB, Folli F, Velloso LA, Saad MJ (2003) Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver. Biol Chem 384:151-159
9. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240-243
10. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM (2001) Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121
11. Kakuma T, Lee Y, Unger RH (2002) Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase. Biochem Biophys Res Commun 297:1259-1263
12. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99:11482-11486
13. Araujo RC, Mori MA, Merino VF, Bascands JL, Schanstra JP, Zollner RL, Villela CA, Nakaie CR, Paiva AC, Pesquero JL et al (2006) Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem 387:431-436
14. Mori MA, Sales VM, Motta FL, Fonseca RG, Alenina N, Guadagnini D, Schadock I, Silva ED, Torres HA, Dos Santos EL et al (2012) Kinin b(1) receptor in adipocytes regulates glucose tolerance and predisposition to obesity. PLoS One 7:e44782
15. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, Oliveira SM, Pesquero JL, Paiva AC, Calixto JB et al (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 97:8140-8145
16. Stansbie D, Brownsey RW, Crettaz M, Denton RM (1976) Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 160:413-416
17. Robinson AM, Williamson DH (1978) Control of glucose metabolism in isolated acini of the lactating mamary gland of the rat. Effects of oleate on glucose utilization and lipogenesis. Biochem J 170:609-613
18. Abe KC, Mori MA, Pesquero JB (2007) Leptin deficiency leads to the regulation of kinin receptors expression in mice. Regul Pept 138:56-58
19. Araujo RC, Kettritz R, Fichtner I, Paiva AC, Pesquero JB, Bader M (2001) Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol Chem 382:91-95
20. Barros CC, Haro A, Russo FJ, Schadock I, Almeida SS, Ribeiro RA, Vanzela EC, Lanzoni VP, Barros FC, Moraes MR et al (2012) Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes. PLoS One 7:e40573
21. Merino VF, Todiras M, Mori MA, Sales VM, Fonseca RG, Saul V, Tenner K, Bader M, Pesquero JB (2009) Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J Mol Med (Berl) 87:953-963
22. Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH, Barzilai N (2007) Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J 21:53-60
23. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350
24. Huang W, Dedousis N, Bhatt BA, O'Doherty RM (2004) Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J Biol Chem 279:21695-21700
25. McGarry JD, Woeltje KF, Kuwajima M, Foster DW (1989) Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 5:271-284
26. Dias JP, Couture R (2012) Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance. Diabetes Obes Metab 14:244-253
27. Schulze-Topphoff U, Prat A, Bader M, Zipp F, Aktas O (2008) Roles of the kallikrein/kinin system in the adaptive immune system. Int Immunopharmacol 8:155-160
28. Soderberg C, Marmur J, Eckes K, Glaumann H, Sallberg M, Frelin L, Rosenberg P, Stal P, Hultcrantz R (2011) Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. APMIS 119:412-420
29. Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, Krebs B, Kraft S, Zahn S, Brocks B et al (2004) Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 40:1106-1115
30. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853-857
31. Singhal NS, Patel RT, Qi Y, Lee YS, Ahima RS (2008) Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295:E331-E338
32. Ailhaud G (2006) Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol 329:570-577, discussion 653-575
33. Sookoian S, Gianotti TF, Rosselli MS, Burgueno AL, Castano GO, Pirola CJ (2011) Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 218:378-385
34. Levesque L, Larrivee JF, Bachvarov DR, Rioux F, Drapeau G, Marceau F (1995) Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta. Br J Pharmacol 116:1673-1679
35. Henkel J, Gartner D, Dorn C, Hellerbrand C, Schanze N, Elz SR, Puschel GP (2011) Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis. Lab Invest 91:1107-1117
36. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM et al (1997) Crystal structure of the obese protein leptin-E100. Nature 387:206-209
37. Tanaka M, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39-52
38. Duka A, Kintsurashvili E, Duka I, Ona D, Hopkins TA, Bader M, Gavras I, Gavras H (2008) Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension 51:1352-1357
39. Marcon R, Claudino RF, Dutra RC, Bento AF, Schmidt EC, Bouzon ZL, Sordi R, Morais RL, Pesquero JB, Calixto JB (2013) Exacerbation of DSS-induced colitis in mice lacking kinin B1 receptor through compensation of up-regulation of kinin B2 receptors: the role of tight junctions and intestinal homeostasis. Br J Pharmacol 168:389-402
40. Barros CC, Haro A, Russo FJ, Schadock I, Almeida SS, Reis FC, Moraes MR, Haidar A, Hirata AE, Mori M et al (2012) Bradykinin inhibits hepatic gluconeogenesis in obese mice. Lab Invest 92:1419-1427